Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results November 3, 2021 Minerva Neurosciences Announces FDA Recommendation for Type C Meeting to Discuss Evidence for Use of Roluperidone as Monotherapy for the Treatment of Negative Symptoms in Patients with Schizophrenia in Advance of Potential NDA Submission November 1, 2021 Minerva Neurosciences to Report Third Quarter 2021 Financial Results and Business Updates on November 8 October 11, 2021 Minerva Neurosciences Announces Promotion of Geoff Race to President September 30, 2021 Minerva Neurosciences Announces Study Results Demonstrating Bioequivalence of Phase 2b, Phase 3, and Planned Commercial Formulations of Roluperidone for Treatment of Negative Symptoms of Schizophrenia September 8, 2021 Minerva Neurosciences Announces Appointment of Dr. Ramana Kuchibhatla as Senior Vice President and Head of Research & Development August 2, 2021 Minerva Neurosciences Reports Second Quarter 2021 Financial Results and Business Updates July 26, 2021 Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021 June 10, 2021 Minerva Neurosciences to Present at JMP Securities Life Sciences Conference May 28, 2021 Minerva Neurosciences to Present at Jefferies Virtual Healthcare Conference May 12, 2021 Minerva Neurosciences Reports First Quarter 2021 Financial Results and Business Updates «...34567...1020...»